APOE and Alzheimer disease: Previous work by our group examining a cohort of neuropathologically confirmed AD patients found that female APOE4 homozygotes with Lewy body (LB) pathology were more likely to experience psychosis compared to female APOE4 non-carriers, whereas in males there was no dose-dependent difference [13].